These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 20645039

  • 1. Acute intraoperative tumour lysis syndrome.
    Alam F, Chin KJ.
    Can J Anaesth; 2010 Oct; 57(10):948-9. PubMed ID: 20645039
    [No Abstract] [Full Text] [Related]

  • 2. Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?
    van der Jagt RH.
    Leuk Res; 2010 Jul; 34(7):856-7. PubMed ID: 20378170
    [No Abstract] [Full Text] [Related]

  • 3. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    Kikuchi T, Miyata A, Fujii S, Kikuchi T.
    Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
    [Abstract] [Full Text] [Related]

  • 4. [Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy].
    Borgeat A, Tran-Thang C, Bachmann F.
    Schweiz Med Wochenschr; 1989 Feb 18; 119(7):227-9. PubMed ID: 2711160
    [Abstract] [Full Text] [Related]

  • 5. Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.
    Diao S, Nichols ED, DiNardo C, Konopleva M, Ning J, Qiao W, Maiti A, DiPippo AJ.
    Am J Hematol; 2021 Mar 01; 96(3):E65-E68. PubMed ID: 33259075
    [No Abstract] [Full Text] [Related]

  • 6. [Severe tumor lysis syndrome in acute lymphatic leukemia].
    Hensel M, Thumser B, Radtke H, Scheurlen PG.
    Internist (Berl); 1989 Dec 01; 30(12):824-6. PubMed ID: 2695492
    [No Abstract] [Full Text] [Related]

  • 7. [The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar].
    Volkova MA, Kaletin GI.
    Ter Arkh; 1992 Dec 01; 64(7):18-21. PubMed ID: 1440359
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA, Lee JE, Kim YG, Kim DJ, Kim K, Ko YH, Oh HY, Kim WS, Huh W.
    Ann Hematol; 2009 Jul 01; 88(7):639-45. PubMed ID: 19030857
    [Abstract] [Full Text] [Related]

  • 9. Relapse and death during first remission in acute myeloid leukemia.
    Yanada M, Garcia-Manero G, Borthakur G, Ravandi F, Kantarjian H, Estey E.
    Haematologica; 2008 Apr 01; 93(4):633-4. PubMed ID: 18379012
    [No Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V, Kochupillai V.
    J Assoc Physicians India; 1983 Aug 01; 31(8):511-4. PubMed ID: 6581155
    [No Abstract] [Full Text] [Related]

  • 11. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug 01; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 12. Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.
    Allen SL, Kolitz JE, Lundberg AS, Bennett JM, Capizzi RL, Budman DR.
    Leuk Res; 2010 Apr 01; 34(4):487-91. PubMed ID: 19748672
    [Abstract] [Full Text] [Related]

  • 13. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A, Simeone E, Tiribelli M, Malagola M, Russo D, Fanin R.
    Am J Hematol; 2009 Oct 01; 84(10):690-2. PubMed ID: 19731308
    [No Abstract] [Full Text] [Related]

  • 14. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
    Nielsen SH, Hasselbalch HC, Birgens HS.
    Ugeskr Laeger; 1991 Oct 14; 153(42):2952-3. PubMed ID: 1949322
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
    Metzeler KH, Boeck S, Christ B, Hausmann A, Stemmler HJ, Parhofer KG, Ostermann H, Hiddemann W, Braess J.
    Leuk Res; 2009 Jul 14; 33(7):e69-72. PubMed ID: 19230970
    [No Abstract] [Full Text] [Related]

  • 16. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
    Robak T, Krykowski E, Matusewicz W, Brodowski L, Hołub A, Drzewoski J.
    Pol Tyg Lek; 1988 Nov 21; 43(47):1508-11. PubMed ID: 3075284
    [No Abstract] [Full Text] [Related]

  • 17. At an increased risk: tumor lysis syndrome.
    McGraw B.
    Clin J Oncol Nurs; 2008 Aug 21; 12(4):563-5. PubMed ID: 18676323
    [No Abstract] [Full Text] [Related]

  • 18. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK, Taher AT, Mahfouz RA, Makarem JA, Shamseddine AI.
    Am J Hematol; 2006 Mar 21; 81(3):220-1. PubMed ID: 16493602
    [No Abstract] [Full Text] [Related]

  • 19. Acute tumor lysis syndrome in Hodgkin disease.
    Mahajan A, Nirmal S, English MW, Jenney ME, Lazda ED.
    Med Pediatr Oncol; 2002 Jul 21; 39(1):69-70. PubMed ID: 12116088
    [No Abstract] [Full Text] [Related]

  • 20. A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy.
    von Lilienfeld-Toal M, Hahn-Ast C, Kirchner H, Flieger D, Dölken G, Glasmacher A.
    Haematologica; 2007 Dec 21; 92(12):1719-20. PubMed ID: 18056004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.